Arkadi M. Rywlin M.D. Department of Pathology and Laboratory Medicine, Mount Sinai Medical Center, 4300 Alton Rd, Miami Beach, FL, United States.
Department of Internal Medicine, Mount Sinai Medical Center, 4300 Alton Rd, Miami Beach, FL, United States.
Pathol Res Pract. 2021 Apr;220:153376. doi: 10.1016/j.prp.2021.153376. Epub 2021 Feb 16.
"Spread through airspace" (STAS) is defined as micropapillary clusters, solid nests or single cells of tumor extending beyond the edge of the tumor into the air spaces of the surrounding lung parenchyma. It is associated with reduced overall survival and disease-free survival. Assessment of STAS in lung cancer appears to be necessary to guide clinical interventions. However, data on the correlation between the status of STAS and other lung cancer clinicopathological parameters are scarce.
We reviewed 240 resected lung cancers and investigated the clinical significance of STAS in relation to other relevant lung cancer clinicopathological variables. We performed univariate and multivariate logistic regression analyses with STAS as a dependent variable.
Of the total 240 patients, STAS was observed in 67 (27.9 %) of them. STAS is highly prevalent in adenocarcinoma with a micropapillary growth pattern (70.0 %) than in other lung cancer growth patterns. STAS was frequently reported in wedge resections (31.0%) than in lobectomy specimens (26.7 %). STAS was significantly associated with advanced pN stage (p < 0.001) and lymphovascular invasion (p = 0.005). In multivariate models, we found that lung cancers in the right lower lobe (RLL) (OR, 2.674; 95 % CI = 1.313-5.448, p = 0.007), micropapillary lung cancer growth pattern (OR = 5.199, 95 % CI = 1.220-22.162, p = 0.026), and pN2 stage (OR = 3.683, 95 % CI = 1.324-10.245, p = 0.013) serve as independent predictors for STAS.
Our findings suggest that the presence of STAS is associated with right lower lobe tumors, micropapillary adenocarcinoma, and pN2 tumor stage. Hence, it could serve as one of the prognostically significant histologic findings in lung cancer. It is thus valid to mandate reporting STAS status in CAP surgical pathology lung cancer case summaries.
“气腔内播散”(STAS)被定义为肿瘤的微乳头状簇、实体巢或单个细胞延伸超出肿瘤边缘进入周围肺实质的气腔。它与总生存期和无病生存期缩短有关。评估肺癌中的 STAS 似乎是指导临床干预的必要条件。然而,关于 STAS 状态与其他肺癌临床病理参数之间相关性的数据却很少。
我们回顾了 240 例接受切除术的肺癌病例,并研究了 STAS 与其他相关肺癌临床病理变量之间的临床意义。我们将 STAS 作为因变量进行单变量和多变量逻辑回归分析。
在 240 例患者中,有 67 例(27.9%)存在 STAS。STAS 在微乳头状生长模式的腺癌中比在其他肺癌生长模式中更为常见(70.0%)。STAS 在楔形切除标本中(31.0%)比在肺叶切除标本中(26.7%)更为常见。STAS 与晚期 pN 分期(p < 0.001)和血管淋巴管侵犯(p = 0.005)显著相关。在多变量模型中,我们发现右肺下叶(RLL)的肺癌(OR,2.674;95%CI = 1.313-5.448,p = 0.007)、微乳头状肺癌生长模式(OR = 5.199,95%CI = 1.220-22.162,p = 0.026)和 pN2 分期(OR = 3.683,95%CI = 1.324-10.245,p = 0.013)是 STAS 的独立预测因素。
我们的研究结果表明,STAS 的存在与右下叶肿瘤、微乳头状腺癌和 pN2 肿瘤分期有关。因此,它可能成为肺癌中具有预后意义的组织学发现之一。因此,在 CAP 外科病理学肺癌病例总结中报告 STAS 状态是有效的。